$ANNX
Annexon, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Brisbane, CA
ANNX chart
What traders are saying about $ANNX
Latest postsAnnexon, Inc. news
- Annexon, Inc. (ANNX) Discusses Vonaprument Phase III ARCHER II Trial in Geographic Atrophy - Slideshow
Seeking Alpha ·
- H.C. Wainwright Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)
The Globe and Mail ·
- Annexon Eyes Q4 2026 Phase III Readout for Vision-Preserving GA Drug
marketbeat.com ·
- ANNX: Phase 2 showed dose-dependent vision protection; ARCHER II’s 15-month analysis is targeted for Q4 2026
TradingView ·
- Annexon to Host Virtual Investor Event on November 3, 2026: Vonaprument for the Treatment of Geographic Atrophy - Highlighting Key Aspects of Phase 3 ARCHER II Trial
Yahoo Finance ·
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting
Yahoo Finance ·
- Annexon to Participate in Upcoming September Investor Conferences
Yahoo Finance ·
- What Annexon (ANNX)'s Dual-Endpoint ARCHER II Update Means For Shareholders
Yahoo Finance ·
- Annexon (ANNX) Q2 2026 Earnings Call Transcript
fool.com ·
- Annexon (ANNX), What Is Behind Its Latest Update?
Yahoo Finance ·
- Annexon, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
Annexon, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$206.7M | -$138.2M | -$134.2M | -$141.9M |
| Diluted EPS | $-1.34 | $-1.01 | $-1.77 | $-2.60 |
| Total assets (year end) | $277.6M | $350.1M | $297.7M | $285.1M |
| Cash and equivalents (year end) | $162.1M | $49.5M | $225.1M | $140.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Annexon, Inc.
- Ticker
- ANNX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Brisbane, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1528115
Frequently asked questions
What exchange is Annexon, Inc. listed on?
Annexon, Inc. trades on the Nasdaq under the ticker symbol ANNX.
What industry is Annexon, Inc. in?
Annexon, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Annexon, Inc. headquartered?
Annexon, Inc.'s business address on file with the SEC is in Brisbane, CA.
When does Annexon, Inc.'s fiscal year end?
Annexon, Inc.'s fiscal year ends on December 31.